Market Place
Sourcing Support
Beyond Cancer Receives Approval for Phase 1b Trial
03 Dec 2024 //
GLOBENEWSWIRE
Beyond Cancer Presents Preclinical LV UNO Therapy Data at SITC
11 Nov 2024 //
GLOBENEWSWIRE
Beyond Air® Schedules Q2 2025 Results Call and Webcast
29 Oct 2024 //
GLOBENEWSWIRE
Mallinckrodt Expands INOmax EVOLVE DS System In US Hospitals
10 Oct 2024 //
PR NEWSWIRE
Beyond Cancer To Present UNO Therapy Data At SITC 2024
07 Oct 2024 //
GLOBENEWSWIRE
Beyond Air Partners to Expand LungFit® PH Access
02 Oct 2024 //
GLOBENEWSWIRE
Beyond Air To Join ROTH Healthcare Opportunities Conference
23 Sep 2024 //
GLOBENEWSWIRE
Beyond Air Publishes Data On Nitric Oxide For Viral Pneumonia
31 Jul 2024 //
GLOBENEWSWIRE
Beyond Cancer`s UNO Shows Immunogenic Response In r/r Solid Tumors
03 Jun 2024 //
GLOBENEWSWIRE
Enzolytics Announces Nitric Oxide Formulation Licensing Intent
22 May 2024 //
ACCESSWIRE
Beyond Cancer: UNO Therapy At ASCO 2024 On Clinical Development
01 May 2024 //
GLOBENEWSWIRE
Beyond Air looks beyond lungs to target nitric oxide in autism
20 Jun 2023 //
FIERCE BIOTECH
Mallinckrodt Announces Submission of 510k to the U.S. FDA for NO Delivery System
28 Sep 2022 //
PRNEWSWIRE
Beyond Air® To Participate in Three Upcoming Investor Conferences
16 Sep 2022 //
GLOBENEWSWIRE
SaNOtize Nitric Oxide Nasal Spray Reduced Viral Load by 99% within Two Days
13 Jul 2022 //
BUSINESSWIRE
Nitric oxide nasal spray significantly shortens the course of COVID 19: Study
13 Jul 2022 //
ET HEALTH
Mallinckrodt to Publish Use of Inhaled NO2 in Hospitalized COVID-19 Patients
11 Apr 2022 //
PRNEWSWIRE
Amrita Hospital, Amrita Vidyapeetham: inhaled nitric oxide kills SARS-COV-2
03 Feb 2022 //
PHARMABIZ
Beyond Air Announces Two Appointments to Beyond Cancer Board of Directors
03 Feb 2022 //
GLOBENEWSWIRE
CHMP recommends approval of Dupixent for ages 6 to 11 years with severe asthma
31 Jan 2022 //
GLOBENEWSWIRE
Beyond Air Provides Regulatory Update for LungFit PH
09 Dec 2021 //
PRESS RELEASE
Beyond Air Reports Financial Results for Q2 of Fiscal Year 2022
11 Nov 2021 //
GLOBENEWSWIRE
Nicox’s NCX 470 Shows Retinal Cell Protection in a Nonclinical Model
29 Sep 2021 //
BIOSPACE
Beyond Air Announces CFO Transition
20 Aug 2021 //
GLOBENEWSWIRE
Mallinckrodt launches retrospective study for inhaled therapy in COVID-19
11 Nov 2020 //
PHARMATIMES
Clinical Study Begins for the First Oral Systemic Nitric Oxide Based Therapeutic
26 Oct 2020 //
PRNEWSWIRE
Nitric oxide a possible treatment for COVID-19
02 Oct 2020 //
EUREKA ALERT
Nicox Selects 0.1% NCX 470 Dose in Adaptive Stage of Mont Blanc Phase 3 Trial
23 Sep 2020 //
GLOBENEWSWIRE
Bellerophon Therapeutics Announces First Patient Treated in Pha3 Clinical Study
13 Jul 2020 //
GLOBENEWSWIRE
Mallinckrodt to fund nitric oxide therapy trial in Covid-19 patients
01 May 2020 //
CLINICALTRIALSARENA
Novan Announces Receipt of Written Minutes from Type C FDA Devp of SB206
30 Apr 2020 //
GLOBENEWSWIRE
Mallinckrodt Supports Investigator-Initiated Study Massachusetts to Nitric Oxide
30 Apr 2020 //
PRNEWSWIRE
Novan crushed by phase 3 failures of antiviral gel
04 Jan 2020 //
FIERCE BIOTECH
MedPharm Expands Relationship With Novan
23 Jul 2019 //
CONTRACT PHARMA
Pfizer Reports Failure in Persistent Pulmonary Hypertension, Progress in DMD
01 Jul 2019 //
BIOSPACE
Mallinckrodt`s INOmax™ (Nitric Oxide) Gas, for Inhalation, Approved in Australia
10 Apr 2019 //
PRNASIA
Praxair Distribution`s Biological Nitric Oxide Receives Approval in US
05 Oct 2018 //
FDA
Praxair Distribution`s Generic Nitric Oxide Receives Approval in US
03 Oct 2018 //
FDA
Nicox and Fera Pharmaceuticals Focus on Rare Disease Indication for Naproxcinod
26 Sep 2018 //
GLOBENEWSWIRE
Setback for AZ as tralokinumab flunks asthma trial
02 Nov 2017 //
PMLIVE
Mallinckrodt Enrolls First Patient In Phase 4 Registry Of INOMAX® (Nitric Oxide)
01 Aug 2017 //
PR NEWSWIRE
Anne Whitaker Named CEO of KNOW Bio Respiratory Company
26 Jan 2017 //
PR NEWSWIRE
Hakko`s study supports L-arginine boosting activity
20 Jan 2017 //
NUTRAINGREDIENTS
Novan Announces Statistically Significant Phase II Clinical Trial Results
05 Dec 2016 //
DRUG DEVELOPMENT
Mallinckrodt`s pharmaceutical gas approved in Australia and Japan
03 Nov 2015 //
BIOSPECTRUM ASIA
Some heartburn drugs may carry heightened risk of heart attack
11 Jun 2015 //
REUTERS
Mallinckrodt Completes Acquisition Of Ikaria
16 Apr 2015 //
FIRST WORD PHARMA
